GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
120 hedge funds and large institutions have $807M invested in Genomic Health, Inc. in 2013 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 44 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
23% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 44
67% less call options, than puts
Call options by funds: $447K | Put options by funds: $1.37M
Holders
120
Holding in Top 10
1
Calls
$447K
Puts
$1.37M
Top Buyers
| 1 | +$9.29M | |
| 2 | +$7.64M | |
| 3 | +$2.99M | |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$2.44M |
| 5 |
Morgan Stanley
New York
|
+$2.35M |
Top Sellers
| 1 | -$10.6M | |
| 2 | -$2.92M | |
| 3 | -$1.83M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.69M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$1.17M |